Sort
48,018 grants matching “immunotherapy”
Comprehensive Cancer Center Program at Fox Chase
$391,000Jonathan D. Chernoff · Research Inst Of Fox Chase Can Ctr · P30 · FY2020 · CA
EASTERN COOPERATIVE ONCOLOGY GROUP
$390,986University Of Pennsylvania · U10 · FY2002 · CA
Treatment of tuberculosis with immunomodulators
$390,890Brigham And Women'S Hospital · R01 · FY2004 · HL
T cell costimulation and regulation in myocarditis
$390,890Brigham And Women'S Hospital · R01 · FY2003 · HL
Molecular Targeted Radionuclide Therapy to Enhance Tumor Cell Susceptibility and Response to Immune Checkpoint Inhibition
$390,879Zachary Scott Morris · University Of Wisconsin-Madison · P01 · FY2020 · CA
Dyslipidemia and Diabetic Retinopathy
$390,876Julia V Busik · Michigan State University · R01 · FY2023 · EY
Dyslipidemia and Diabetic Retinopathy
$390,876Julia V Busik · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2024 · EY
Dyslipidemia and Diabetic Retinopathy
$390,876Julia V Busik · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2025 · EY
Project 2: Spatial Architecture of Tumor-Mediated Immunosuppression
$390,850Garry P Nolan · Stanford University · U54 · FY2017 · CA
Strategies to improve outcomes for TNBC patients that integrate subtype-specific genomic and immune-based discoveries
$390,826Jennifer A Pietenpol · Vanderbilt University Medical Center · P50 · FY2021 · CA
INTERLEUKIN 2 IMMUNOTHERAPY FOR HCV INFECTION
$390,814Weill Medical College Of Cornell Univ · U01 · FY2002 · AI
Pro-tumor functions of neutrophils in squamous cell lung cancer
$390,763Trudy Gale Oliver · Duke University · R01 · FY2024 · CA
Mutant BRAF as a Therapeutic Target for Melanoma
$390,723Dorothee M Herlyn · Wistar Institute · P01 · FY2010 · CA
Gene circuits programming IL-17 production in innate lymphocytes
$390,688Joonsoo Kang · Univ Of Massachusetts Med Sch Worcester · R01 · FY2013 · AI
Investigating the prognostic role of intrinsic immune evasion mechanisms in HNSCC
$390,669Xuefeng Wang · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2023 · DE
Validating Urine Derived Cancer Cells (UDCC) -- Non-Invasive and Living Liquid Biopsies -- in Bladder Cancer Clinics
$390,660Xuefeng Liu · Ohio State University · R33 · FY2021 · CA
Cytokine regulation of anti-helminth immunity
$390,611David Artis · Weill Medical Coll Of Cornell Univ · R01 · FY2014 · AI
Mechanisms of Vaccinia Virus Innate Immune Inhibition
$390,601William Lawrence Marshall · Univ Of Massachusetts Med Sch Worcester · R01 · FY2011 · AI
Targeted MEK inhibition to enhance immunotherapy in cholangiocarcinoma
$390,583Gregory B. Lesinski · Emory University · R01 · FY2019 · CA
Proj 2 - Lymphatic system as a conduit for age-related defective proteostasis in AD
$390,566Laura Santambrogio · Albert Einstein College Of Medicine · P01 · FY2020 · AG
Mapping the Critical Epitopes of Ara h 2 and Ara h 6
$390,538Stephen C. Dreskin · University Of Colorado Denver · R01 · FY2015 · AI
Development and Pre-Clinical Validation of Quantitative Imaging of Cell State Kinetics (QuICK) for Functional Precision Oncology
$390,494Thomas Andrew Zangle · University Of Utah · R01 · FY2023 · CA
UNIVERSITY OF COLORADO SOUTHWEST ONCOLOGY GROUP
$390,453University Of Colorado Denver · U10 · FY2002 · CA
Developmental Funds
$390,453Primo N Lara · University Of California At Davis · P30 · FY2019 · CA
Biased chemokine receptor signaling in cancer progression
$390,452Michael B Dwinell · Medical College Of Wisconsin · R01 · FY2020 · CA